NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,730,000 | +11.0% | 49,090 | +1.5% | 3.25% | -6.8% |
| Q2 2022 | $3,360,000 | -17.0% | 48,345 | -1.1% | 3.48% | +18.3% |
| Q1 2022 | $4,048,000 | +22.6% | 48,860 | +11.1% | 2.94% | +45.3% |
| Q4 2021 | $3,302,000 | -14.6% | 43,975 | +32.1% | 2.03% | -20.5% |
| Q3 2021 | $3,866,000 | -26.7% | 33,280 | +40.0% | 2.55% | -26.4% |
| Q2 2021 | $5,274,000 | +53.6% | 23,775 | -8.5% | 3.47% | +44.1% |
| Q1 2021 | $3,434,000 | -29.7% | 25,982 | -8.0% | 2.41% | -38.2% |
| Q4 2020 | $4,885,000 | +32.9% | 28,232 | -14.5% | 3.89% | +6.1% |
| Q3 2020 | $3,677,000 | +72.5% | 33,032 | -8.1% | 3.67% | +58.6% |
| Q2 2020 | $2,131,000 | -24.2% | 35,942 | -14.0% | 2.31% | -36.8% |
| Q1 2020 | $2,813,000 | -36.9% | 41,779 | -21.0% | 3.66% | -16.3% |
| Q4 2019 | $4,457,000 | – | 52,889 | – | 4.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |